World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
86
Citations
41052
World Ranking
813
National Ranking
430

David O. Morgan publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where David O. Morgan sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 156 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

David O. Morgan D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where David O. Morgan sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 86 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2012 - Fellow of the Royal Society, United Kingdom

Overview

David O. Morgan is affiliated with the University of California, San Francisco in the United States. Their research focuses primarily on biochemistry, genetics, and molecular biology, with significant contributions in the subfields of molecular biology, cell biology, infectious diseases, ecology, and plant science.

Their recent scholarly output includes works published between 2020 and 2023, reflecting diverse interests in molecular mechanisms and viral biology. Notable papers include:

  • Phosphoregulation of Phase Separation by the SARS-CoV-2 N Protein Suggests a Biophysical Basis for its Dual Functions (2020) in Molecular Cell
  • Childhood Asthma Incidence, Early and Persistent Wheeze, and Neighborhood Socioeconomic Factors in the ECHO/CREW Consortium (2022) in JAMA Pediatrics
  • Structural basis of human separase regulation by securin and CDK1-cyclin B1 (2021) in Nature
  • Reconstitution of the SARS-CoV-2 ribonucleosome provides insights into genomic RNA packaging and regulation by phosphorylation (2022) in Journal of Biological Chemistry
  • Assembly of SARS-CoV-2 ribonucleosomes by truncated N∗ variant of the nucleocapsid protein (2023) in Journal of Biological Chemistry

David O. Morgan has collaborated frequently with several researchers, including Christopher R. Carlson, Armin N. Adly, Nairi Hartooni, Jonathan B Asfaha, and Chloe M. Ghent. These partnerships underscore interdisciplinary research efforts in their areas of expertise.

Their publications are often found in venues such as bioRxiv (Cold Spring Harbor Laboratory), Journal of Biological Chemistry, Nature Communications, Current Biology, and Science Advances, indicating active engagement with high-impact scientific journals.

Their main research topics encompass:

  • Microtubule and mitosis dynamics
  • Bacteriophages and microbial interactions
  • Genomics and chromatin dynamics
  • SARS-CoV-2 and COVID-19 research
  • RNA and protein synthesis mechanisms
  • Advanced biosensing and bioanalysis techniques
  • Ubiquitin and proteasome pathways

David O. Morgan was recognized as a Fellow of the Royal Society, United Kingdom, in 2012, reflecting a milestone in their scientific career.

Best Publications

  • Principles of CDK regulation

    David O. Morgan

  • Cyclin-dependent kinases: engines, clocks, and microprocessors.

    David O. Morgan

  • Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle

    Koff A;Giordano A;Desai D;Yamashita K

  • Crystal structure of cyclin-dependent kinase 2.

    De Bondt Hl;Rosenblatt J;Jancarik J;Jones Hd

  • A chemical switch for inhibitor-sensitive alleles of any protein kinase

    Anthony C. Bishop;Jeffrey A. Ubersax;Dejah T. Petsch;Dina P. Matheos

  • Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose

    Leland Ellis;Eric Clauser;David O. Morgan;Marc Edery

  • Targets of the cyclin-dependent kinase Cdk1

    Jeffrey A. Ubersax;Erika L. Woodbury;Erika L. Woodbury;Phuong N. Quang;Phuong N. Quang;Maria Paraz;Maria Paraz

  • Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

    Jianglin He;S. Choe;R. Walker;P. Di Marzio

  • Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors.

    Nathanael S. Gray;Lisa Wodicka;Andy-Mark W. H. Thunnissen;Thea C. Norman

  • Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit

    Yong Gu;Christoph W. Turck;David O. Morgan

  • Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution

    Liam J. Holt;Brian B. Tuch;Judit Villén;Alexander D. Johnson

  • Insulin-like growth factor II receptor as a multifunctional binding protein.

    David O. Morgan;David O. Morgan;Jeffrey C. Edman;David N. Standring;Victor A. Fried

  • A novel cyclin associates with M015/CDK7 to form the CDK-activating kinase

    Robert P. Fisher;David O. Morgan

  • Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15

    Yong Gu;Jody Rosenblatt;David O. Morgan

  • Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14.

    Sue L. Jaspersen;Julia F. Charles;David O. Morgan

  • Cdk-activating kinase complex is a component of human transcription factor TFIIH

    Ramin Shiekhattar;Fred Mermelstein;Robert P. Fisher;Ronny Drapkin

  • Cyclin-dependent kinases: a family portrait

    Marcos Malumbres;Edward Harlow;Tim Hunt;Tony Hunter

  • Control of mitosis by changes in the subcellular location of cyclin-B1–Cdk1 and Cdc25C

    Catherine G Takizawa;David O Morgan

  • Finishing mitosis, one step at a time

    Matt Sullivan;David O. Morgan

  • Regulation of the APC and the exit from mitosis.

    David O. Morgan

Frequent Co-Authors

Richard A. Roth
Richard A. Roth Stanford University
Alexander D. Johnson
Alexander D. Johnson University of California, San Francisco
Keith Roberts
Keith Roberts John Innes Centre
Bruce Alberts
Bruce Alberts University of California, San Francisco
Peter Walter
Peter Walter University of California, San Francisco
Martin Raff
Martin Raff University College London
Kevan M. Shokat
Kevan M. Shokat University of California, San Francisco
William J. Rutter
William J. Rutter University of California, San Francisco
Robert P. Fisher
Robert P. Fisher Icahn School of Medicine at Mount Sinai
Harold E. Varmus
Harold E. Varmus Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA opens doors to a wide range of online degree options and career pathways. Many students begin by considering different accredited online programs that fit their needs, especially when balancing work or family. For those interested in nursing, comparing capella vs chamberlain rn to bsn programs can help you identify curriculum strengths and flexibility that align with your career goals.

As you advance in your profession, seamless transitions can be essential. For example, bsn to msn online programs offer a direct bridge for current nurses aiming to expand their qualifications and access leadership opportunities. It’s also important to consider the reputation and mission of your institution; non profit universities are recognized for their focus on student outcomes and academic quality.

Military-affiliated students can leverage programs tailored to their unique needs. The best military friendly colleges support flexible schedules, credit for military experience, and offer resources for veterans. By considering these pathways, you can tailor your studies and future career in molecular biology, healthcare, or related fields.

Best Scientists Citing David O. Morgan

Trending Scientists

Recently Published Articles